The Two Faces of Bacterial Membrane Vesicles: Pathophysiological Roles and Therapeutic Opportunities. [PDF]
Antibiotics (Basel), 2023 Thapa HB, Ebenberger SP, Schild S.
europepmc +1 more source
Toward a Shigella Vaccine: Opportunities and Challenges to Fight an Antimicrobial-Resistant Pathogen. [PDF]
Int J Mol Sci, 2023 Raso MM, Arato V, Gasperini G, Micoli F.
europepmc +1 more source
Outer membrane vesicles: Versatile nanocarriers for therapeutic delivery and immune modulation. [PDF]
Acta Pharm Sin BYang J +6 more
europepmc +1 more source
Hit 'em Where It Hurts: Gram-Negative Bacterial Lipopolysaccharide as a Vaccine Target. [PDF]
Microbiol Mol Biol Rev, 2023 Cross AS.
europepmc +1 more source
The Central Importance of Vaccines to Mitigate the Threat of Antibiotic-Resistant Bacterial Pathogens. [PDF]
Vaccines (Basel)Zhang JA, Nizet V.
europepmc +1 more source
Evolution of Vaccines Formulation to Tackle the Challenge of Anti-Microbial Resistant Pathogens. [PDF]
Int J Mol Sci, 2023 Tognetti F +5 more
europepmc +1 more source
Safety and Immunogenicity of a 4-Component Generalized Modules for Membrane Antigens Shigella Vaccine in Healthy European Adults: Randomized, Phase 1/2 Study. [PDF]
J Infect DisLeroux-Roels I +25 more
europepmc +1 more source
A Shigella flexneri 2a synthetic glycan-based vaccine induces a long-lasting immune response in adults. [PDF]
NPJ Vaccines, 2023 Meron-Sudai S +9 more
europepmc +1 more source
Immunogenicity evaluation of altSonflex1-2-3 <i>Shigella</i> vaccine across mice, rats, and rabbits to inform human translational insights. [PDF]
Front ImmunolCaradonna V +10 more
europepmc +1 more source